Zynerba Pharmaceuticals Inc. (ZYNE) Rose To Over An 8-Month High

Zynerba Pharmaceuticals Inc. (ZYNE) announced Tuesday morning that it has initiated its exploratory Phase 2 clinical trial of ZYN002 cannabidiol gel in children with Fragile X syndrome.

from RTT - Before the Bell http://ift.tt/2hQHX0W
via IFTTT